The demand for bone grafts and substitutes in Japan is projected to grow from USD 174.5 million in 2025 to USD 219.6 million by 2035, at a CAGR of 2.3%. On-Body Injectors will dominate with a 22.4% market share, while oncology will lead the deployment mode segment with a 21.4% share.